The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation
Authors:
- Anjli VenkateswaranAVAnjli Venkateswaran
- Marc LavenderMLMarc Lavender
- Krista Md La PerleKPKrista Md La Perle
- Je-Yoel ChoJCJe-Yoel Cho
- Michael L RobinsonMRMichael L Robinson
- Sissy M JhiangSJSissy M Jhiang
- 19 November 2002
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 21 (53) , 8166-8172
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 10 references indexed in Scilit:
- RET Oncogene Activation in Papillary Thyroid CarcinomaAdvances in Anatomic Pathology, 2001
- Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53−/− miceOncogene, 2001
- The RET proto-oncogene in human cancersOncogene, 2000
- Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic miceOncogene, 1999
- Ganglioneuromas and renal anomalies are induced by activated RETMEN2B in transgenic miceOncogene, 1999
- Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse linesOncogene, 1999
- Signal Transduction Pathways Activated by RET Oncoproteins in PC12 Pheochromocytoma CellsJournal of Biological Chemistry, 1998
- Signal Transduction by the Receptor Tyrosine Kinase Ret1998
- Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.Endocrinology, 1996
- Inositol phosphates and cell signallingNature, 1989